Evaluation of Antihyperlipidemic Activity of Mimusops elengi L. in Triton WR- 1339 Induced Hyperlipidaemia in Rats
Objective: The present study was undertaken to explore antihyperlipidemic effect of ethanolic extract of Mimusops elengi L. (ME) in Triton WR-1339 induced hyperlipidemia in rats. Materials and methods: The wistar rats were divided in to Normal control (NC), Hyperlipidemic group (HG), Fenofibrate group (FG), Mimusops elengi L. (ME) treated groups (100, 300, 600 mg/kg, p.o.). Hyperlipidemia in all groups was induced by single i.p. injection of Triton WR-1339 at a dose of 200 mg/kg except normal control. Result: The groups treated with Mimusops elengi L. showed significant reduction (p<0.01) in levels of triglyceride and total cholesterol as compared t o HG after 7 and 24 h of induction. Even after 48 h the groups treated with Mimusops elengi L. showed significant decrease (p<0.01) in level of triglyceride in groups ME 300, ME 600 and significant decrease (p<0.05) in level of tota l cholesterol in groups ME 300, ME 600 respectively as compared to HG. Moreover HDL level was significantly elevated (p<0.01) in the groups ME 300, ME 600 after 7 and 24 h, however it was significantly elevated (p<0.0 1) only in ME 600 after 48 h of the treatment. Conclusion: Hence it can be concluded that Mimusops elengi L. has significant antihyperlipidemic effect owing to its ability to reduce the levels of total cholesterol, triglyceri de and increasing the level of HDL.
Hyperlipidemia, Mimusops elengi L., Triton WR- 1339.
Pharmacy and Pharmacology
- There are currently no refbacks.
This work is licensed under a Creative Commons Attribution 4.0 International License.